PT1499888E - Péptidos conformacionalmente constrangidos que se ligam ao receptor orl-1 - Google Patents

Péptidos conformacionalmente constrangidos que se ligam ao receptor orl-1 Download PDF

Info

Publication number
PT1499888E
PT1499888E PT03736501T PT03736501T PT1499888E PT 1499888 E PT1499888 E PT 1499888E PT 03736501 T PT03736501 T PT 03736501T PT 03736501 T PT03736501 T PT 03736501T PT 1499888 E PT1499888 E PT 1499888E
Authority
PT
Portugal
Prior art keywords
orl
receptor
present
conformationally constrained
bind
Prior art date
Application number
PT03736501T
Other languages
English (en)
Inventor
Donald J Kyle
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of PT1499888E publication Critical patent/PT1499888E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT03736501T 2002-04-29 2003-04-29 Péptidos conformacionalmente constrangidos que se ligam ao receptor orl-1 PT1499888E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37674502P 2002-04-29 2002-04-29

Publications (1)

Publication Number Publication Date
PT1499888E true PT1499888E (pt) 2010-10-14

Family

ID=29401398

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03736501T PT1499888E (pt) 2002-04-29 2003-04-29 Péptidos conformacionalmente constrangidos que se ligam ao receptor orl-1

Country Status (12)

Country Link
US (1) US20040259775A1 (pt)
EP (1) EP1499888B1 (pt)
AT (1) ATE473439T1 (pt)
AU (1) AU2003237119A1 (pt)
CY (1) CY1111243T1 (pt)
DE (1) DE60333270D1 (pt)
DK (1) DK1499888T3 (pt)
ES (1) ES2348604T3 (pt)
HK (1) HK1122098A1 (pt)
PT (1) PT1499888E (pt)
SI (1) SI1499888T1 (pt)
WO (1) WO2003093294A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050266575A1 (en) * 2004-05-27 2005-12-01 Mayo Kevin H Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics
ITFE20050003A1 (it) * 2005-02-15 2006-08-16 Ufpeptides S R L Agonisti pieni e parziali ed antagonisti del recettore per nocicettina/orfanina fq ad elevata potenza.
US8680050B2 (en) * 2009-02-03 2014-03-25 Amunix Operating Inc. Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
US8703717B2 (en) 2009-02-03 2014-04-22 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
DK2393828T3 (en) 2009-02-03 2017-01-23 Amunix Operating Inc Extended recombinant polypeptides and compositions comprising same
DK2440241T3 (en) * 2009-06-08 2017-10-02 Amunix Operating Inc GROWTH HORMON POLYPEPTIDES AND PROCEDURES FOR PREPARING AND USING THEREOF
US9849188B2 (en) 2009-06-08 2017-12-26 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
SG177752A1 (en) 2009-07-27 2012-03-29 Trigemina Inc Methods for treatment of pain
FR2948809B1 (fr) * 2009-07-31 2012-08-17 St Microelectronics Rousset Amplificateur de lecture faible puissance auto-minute
WO2011123830A2 (en) 2010-04-02 2011-10-06 Amunix Operating Inc. Alpha 1-antitrypsin compositions and methods of making and using same
WO2011123813A2 (en) * 2010-04-02 2011-10-06 Amunix Operating Inc. Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
WO2014102590A1 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted piperidin-4-amino-type compounds and uses thereof
WO2014102588A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US9951038B2 (en) 2012-12-27 2018-04-24 Purdue Pharma L.P. Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
JP7030517B2 (ja) 2015-01-07 2022-03-07 トライジェミナ, インコーポレイテッド マグネシウム含有オキシトシン製剤および使用の方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US5098995A (en) * 1987-05-22 1992-03-24 The Salk Institute For Biological Studies GRF Analogs VIIA
US5639726A (en) * 1994-09-30 1997-06-17 The Regents Of The University Of Michigan Peptide mediated enhancement of thrombolysis methods and compositions
US5821219A (en) * 1995-08-11 1998-10-13 Oregon Health Sciences University Opioid antagonists and methods of their use
AU8334298A (en) * 1997-07-15 1999-02-10 Novo Nordisk A/S Nociceptin analogues
US6777388B1 (en) * 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US6586403B1 (en) * 2000-07-20 2003-07-01 Salpep Biotechnology, Inc. Treating allergic reactions and inflammatory responses with tri-and dipeptides
AU2003225073A1 (en) * 2002-04-18 2003-11-03 The University Of Iowa Research Foundation Methods of inhibiting and treating bacterial biofilms by metal chelators

Also Published As

Publication number Publication date
SI1499888T1 (sl) 2010-11-30
CY1111243T1 (el) 2015-06-11
DK1499888T3 (da) 2010-10-25
ATE473439T1 (de) 2010-07-15
EP1499888A2 (en) 2005-01-26
AU2003237119A8 (en) 2003-11-17
EP1499888B1 (en) 2010-07-07
WO2003093294A3 (en) 2004-09-23
DE60333270D1 (de) 2010-08-19
EP1499888A4 (en) 2005-10-19
AU2003237119A1 (en) 2003-11-17
WO2003093294A2 (en) 2003-11-13
US20040259775A1 (en) 2004-12-23
HK1122098A1 (en) 2009-05-08
ES2348604T3 (es) 2010-12-09

Similar Documents

Publication Publication Date Title
HK1122098A1 (en) Conformationally constrained peptides that bind the orl-1 receptor
Hruby et al. Conformation–activity relationships of opioid peptides with selective activities at opioid receptors
IL134796A0 (en) Noribogaine in the treatment of pain and drug addiction
EE200200510A (et) POL1212 aminohappejärjestust kodeeriv DNA, seda sisaldav ekspressioonivektor, sea modifitseeritud VIII- tegur, sellel põhinev ravimkompositsioon ningmeetod sea modifitseeritud VIII-teguri aminohappejärjestust omava valgu valmistamiseks
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
ATE361318T1 (de) Polypeptiden, die die april-vermittelte aktivierung von t-und b-zellen hemmen
AU2003216321A1 (en) Tamper-resistant transdermal opioid delivery devices
IS4261A (is) Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
BR0309550A (pt) analgésicos hìbridos quiméricos
DE69736634D1 (de) Antagonisten des intestinotrophen glp-2 peptides
DE602004006869D1 (de) 5ht2c rezeptor agonisten zur behandlung von diabetes und fettleibigkeit
HUP0101546A2 (hu) Opioid antagonistát és NMDA-receptor komplex modulátort tartalmazó gyógyászati készítmény alkohol- és drogfüggőség kezelésére
HUP0401485A2 (hu) Kiválasztott opioidok és muszkarin-antagonisták kombinációját tartalmazó gyógyszerkészítmény vizeletinkontinencia kezelésére
CN101454338A (zh) κ阿片样受体肽的N-氧化物
CY1110152T1 (el) Χρηση συνδυασμου μορφινης και τουλαχιστον ενος ανταγωνιστη φυσικου οπιοειδους στην αγωγη της εξαρτησης απο φυσικα οπιοειδη και στην προληψη της μη στοματικης καταχρησης φυσικων οπιοειδων σε εξαρτημενους απο φυσικα οπιοειδη
HUP0401915A2 (hu) 4-[4-Piperidinilidén-(3-karbamoil-fenil)-metil]-benzamid-származékok és alkalmazásuk fájdalom, gerincsérülések vagy gasztrointesztinális rendellenességek kezelésére és ezeket tartalmazó gyógyszerkészítmények
Hingne et al. Blockade of NMDA receptors prevents analgesic tolerance to repeated transcutaneous electrical nerve stimulation (TENS) in rats
MXPA05004973A (es) Agentes para aliviar el dolor.
Hiramatsu et al. Long‐lasting antinociceptive effects of a novel dynorphin analogue, Tyr‐D‐Ala‐Phe‐Leu‐Arg ψ (CH2NH) Arg‐NH2, in mice
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
GB0120022D0 (en) Conjugate
Feng et al. Crosstolerance between butorphanol and morphine in rats
DE60330857D1 (de) 5-ht4 antagonisten zur behandlung von herzversagen
Society Public policy statement on the rights and responsibilities of health care professionals in the use of opioids for the treatment of pain: A consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine
WO2003106666A3 (en) VARIANTS OF PROTEIN C WITH MODIFIED PROPERTIES